Science | Nature | Cell | View More
Natural Products
Ziyuglycoside II
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Ziyuglycoside II
Price: $118 / 20mg
CAS No.: 35286-59-0
Catalog No.: CFN98465
Molecular Formula: C35H56O8
Molecular Weight: 604.8 g/mol
Purity: >=98%
Type of Compound: Triterpenoids
Physical Desc.: Powder
Source: The roots of Sanguisorba officinalis.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Download: COA    MSDS    SDF    Manual
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / $35.9 / In-stock
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Warszawski Uniwersytet Medyczny (Poland)
  • University of Beira Interior (Portugal)
  • University of Pretoria (South Africa)
  • Universidad de Antioquia (Colombia)
  • Kyoto University (Japan)
  • Universidade Católica Portuguesa (Portugal)
  • Pennsylvania State University (USA)
  • University of Perugia (Italy)
  • Universite Libre de Bruxelles (Belgium)
  • University of Queensland (Australia)
  • Florida International University (USA)
  • More...
Package
Featured Products
Ganoderenic acid A

Catalog No: CFN92236
CAS No: 100665-40-5
Price: $318/10mg
Costunolide

Catalog No: CFN98928
CAS No: 553-21-9
Price: $40/20mg
Squalene

Catalog No: CFN99208
CAS No: 111-02-4
Price: $30/20mg
Syringaresinol

Catalog No: CFN92060
CAS No: 487-35-4
Price: $268/10mg
Rosmarinic acid

Catalog No: CFN99103
CAS No: 20283-92-5
Price: $40/20mg
Magnolignan A

Catalog No: CFN96188
CAS No: 93673-81-5
Price: $318/10mg
6-Methoxyluteolin

Catalog No: CFN92706
CAS No: 520-11-6
Price: $268/20mg
Umckalin

Catalog No: CFN70362
CAS No: 43053-62-9
Price: $ / mg
Momordicoside K

Catalog No: CFN92305
CAS No: 81348-84-7
Price: $ / mg
beta-Eudesmol

Catalog No: CFN99537
CAS No: 473-15-4
Price: $288/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Ziyuglycoside II has a wide range of clinical applications including hemostasis, antibiosis, anti-inflammation and anti-oxidation. Ziyuglycoside II has inhibitory effect on the growth of MDA-MB-435 cells, it induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.Ziyuglycoside II methyl ester possess improved anti-diabetic properties, and has hepato-renal protective activities in type 2 diabetes.
Targets: ROS | JNK | p21 | Bcl-2/Bax | Caspase | p53
In vitro:
Toxicol Lett. 2014 May 16;227(1):65-73.
Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.[Pubmed: 24680927]
Ziyuglycoside II, a triterpenoid saponin compound extracted from Sanguisorba officinalis L., has been reported to have a wide range of clinical applications including anti-cancer effect. In this study, the anti-proliferative effect of Ziyuglycoside II in two classic human breast cancer cell lines, MCF-7 and MDA-MB-231, was extensively investigated.
METHODS AND RESULTS:
Our study indicated that Ziyuglycoside II could effectively induce G2/M phase arrest and apoptosis in both cell lines. Cell cycle blocking was associated with the down-regulation of Cdc25C, Cdc2, cyclin A and cyclin B1 as well as the up-regulation of p21/WAF1, phospho-Cdc25C and phospho-Cdc2. Ziyuglycoside II treatment also induced reactive oxygen species (ROS) production and apoptosis by activating the extrinsic/Fas/FasL pathway as well as the intrinsic/mitochondrial pathway. More importantly, the c-Jun NH2-terminal kinase (JNK), a downstream target of ROS, was found to be a critical mediator of Ziyuglycoside II-induced cell apoptosis. Further knockdown of JNK by siRNA could inhibit Ziyuglycoside II-mediated apoptosis with attenuating the up-regulation of Bax and Fas/FasL as well as the down-regulation of Bcl-2. Taken together, the cell death of breast cancer cells in response to Ziyuglycoside II was dependent upon cell cycle arrest and cell apoptosis via a ROS-dependent JNK activation pathway.
CONCLUSIONS:
Our findings may significantly contribute to the understanding of the anti-proliferative effect of Ziyuglycoside II, in particular to breast carcinoma and provide novel insights into the potential application of such compound in breast cancer therapy.
In vivo:
Nutrients. 2015 Jul 7;7(7):5469-83.
Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice.[Pubmed: 26198246]
Type 2 diabetes is a metabolic disorder caused by abnormal carbohydrate metabolism, and closely associated with abnormal lipid metabolism and hepato-renal dysfunction. This study investigated the anti-diabetic and hepato-renal protective properties of ziyuglycoside I (ZG01) derivative on type 2 diabetes.
METHODS AND RESULTS:
ZG01 was isolated from roots of Sanguisorba officinalis and chemically modified by deglycosylation and esterification to obtained Ziyuglycoside II methyl ester (ZG02-ME). Here, we showed that ZG02-ME has stronger anti-diabetic activity than the original compound (ZG01) through decreasing blood glucose, glycated hemoglobin (HbA1c), and insulin levels in a mouse model of type 2 diabetes (db/db mice). We further found that ZG02-ME treatment effectively ameliorated serum insulin, leptin and C-peptide levels, which are key metabolic hormones, in db/db mice. In addition, we showed that elevated basal blood lipid levels were decreased by ZG02-ME treatment in db/db mice. Furthermore, treatment of ZG02-ME significantly decreased serum AST, ALT, BUN, creatinine, and liver lipid peroxidation in db/db mice.
CONCLUSIONS:
These results demonstrated that compared to ZG01, chemically modified ZG02-ME possess improved anti-diabetic properties, and has hepato-renal protective activities in type 2 diabetes.
Ziyuglycoside II Description
Source: The roots of Sanguisorba officinalis.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Pueroside B

Catalog No: CFN95141
CAS No: 100692-54-4
Price: $288/10mg
Ganoderenic acid K

Catalog No: CFN95469
CAS No: 942950-94-9
Price: $318/10mg
2-O-cinnamoyl-beta-D-glucose

Catalog No: CFN95111
CAS No: N/A
Price: $218/5mg
6-Methoxyfraxinellone

Catalog No: CFN95485
CAS No: N/A
Price: $318/10mg
Methyl ganoderate E

Catalog No: CFN95582
CAS No: 98718-43-5
Price: $413/5mg
New compound 15

Catalog No: CFN95413
CAS No: N/A
Price: $413/5mg
Peltatoside 7-O-beta-glucopyranosi...

Catalog No: CFN95565
CAS No: 813466-12-5
Price: $318/20mg
10-Carboxyloganin

Catalog No: CFN95452
CAS No: 182172-02-7
Price: $318/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.6534 mL 8.2672 mL 16.5344 mL 33.0688 mL 41.336 mL
5 mM 0.3307 mL 1.6534 mL 3.3069 mL 6.6138 mL 8.2672 mL
10 mM 0.1653 mL 0.8267 mL 1.6534 mL 3.3069 mL 4.1336 mL
50 mM 0.0331 mL 0.1653 mL 0.3307 mL 0.6614 mL 0.8267 mL
100 mM 0.0165 mL 0.0827 mL 0.1653 mL 0.3307 mL 0.4134 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Cell Research:
Braz J Med Biol Res. 2013 Aug;46(8):670-5.
Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway.[Pubmed: 23969976]
Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of Ziyuglycoside II on human gastric carcinoma BGC-823 cells.
METHODS AND RESULTS:
We investigated the effects of Ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that Ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway.
CONCLUSIONS:
Our study is the first to report the antitumor potential of Ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.
Structure Identification:
J Sep Sci. 2015 Apr 17.
Development and validation of a quantification method for ziyuglycoside I and II in rat plasma: Application to their pharmacokinetic studies.[Pubmed: 25885584]
This study provided a novel and generally applicable method to determine ziyuglycoside I and Ziyuglycoside II in rat plasma based on liquid chromatography with tandem mass spectrometry.
METHODS AND RESULTS:
A single step of liquid-liquid extraction with n-butanol was utilized, and ginsenoside Rg3 was chosen as internal standard. Final extracts were analyzed based on liquid chromatography with tandem mass spectrometry. Chromatographic separation was achieved using a Thermo Golden C18 column, and the applied gradient elution program allowed for the simultaneous determination of two ziyuglycosides in a one-step chromatographic separation with a total run time of 10 min. The fully validated methodology for both analytes demonstrated high sensitivity (the lower limit of quantitation was 2.0 ng/mL), good accuracy (% RE ≤ ± 15) and precision (% RSD ≤ 15). The average recoveries of both ziyuglycosides and internal standard were all above 75% and no obvious matrix effect was found. This method was then successfully applied to the preclinical pharmacokinetic studies of ziyuglycoside I and Ziyuglycoside II.
CONCLUSIONS:
The presently developed methodology would be useful for the preclinical and clinical pharmacokinetic studies for ziyuglycoside I and Ziyuglycoside II.
Ganoderenic acid A

Catalog No: CFN92236
CAS No: 100665-40-5
Price: $318/10mg
Costunolide

Catalog No: CFN98928
CAS No: 553-21-9
Price: $40/20mg
Squalene

Catalog No: CFN99208
CAS No: 111-02-4
Price: $30/20mg
Syringaresinol

Catalog No: CFN92060
CAS No: 487-35-4
Price: $268/10mg
Rosmarinic acid

Catalog No: CFN99103
CAS No: 20283-92-5
Price: $40/20mg
Magnolignan A

Catalog No: CFN96188
CAS No: 93673-81-5
Price: $318/10mg
6-Methoxyluteolin

Catalog No: CFN92706
CAS No: 520-11-6
Price: $268/20mg
Umckalin

Catalog No: CFN70362
CAS No: 43053-62-9
Price: $ / mg
Momordicoside K

Catalog No: CFN92305
CAS No: 81348-84-7
Price: $ / mg
beta-Eudesmol

Catalog No: CFN99537
CAS No: 473-15-4
Price: $288/20mg
Tags: buy Ziyuglycoside II | Ziyuglycoside II supplier | purchase Ziyuglycoside II | Ziyuglycoside II cost | Ziyuglycoside II manufacturer | order Ziyuglycoside II | Ziyuglycoside II distributor